C-9 , 37th Parliament, 3rd session Monday, February 2, 2004, to Sunday, May 23, 2004
An Act to amend the Patent Act and the Food and Drugs Act (The Jean Chrétien Pledge to Africa)
This bill received royal assent on Friday, May 14, 2004
Statutes of Canada 2004, c. 23
Note concerning the date of Royal Assent: When the date of a written declaration differs from that of Royal Assent, the date shown in LEGISInfo corresponds to the date on which the two Houses of Parliament have been notified of the written declaration. Section 5 of the Royal Assent Act, S.C. 2002, c. 15, states: “Where royal assent is signified by written declaration, the Act is deemed to be assented to on the day on which the two Houses of Parliament have been notified of the declaration.”
Progress
House of Commons
End of stage activity
Introduction and first reading, Thursday, February 12, 2004
Chamber sittings
| Sitting date | Debates (Hansard) |
|---|---|
Thursday, February 12, 2004 |
End of stage activity
Second reading and referral to committee, Thursday, February 12, 2004
Chamber sittings
| Sitting date | Debates (Hansard) |
|---|---|
Thursday, February 12, 2004 |
Sitting 9
Agreed to
(Journals 9)
|
End of stage activity
Committee report presented, Friday, April 23, 2004
Committee meetings
| Meeting date | Minutes |
|---|---|
Tuesday, February 24, 2004 |
Meeting 2 |
Thursday, February 26, 2004 |
Meeting 4 |
Tuesday, March 9, 2004 |
Meeting 5 |
Wednesday, March 10, 2004 |
Meeting 6 |
Thursday, March 11, 2004 |
Meeting 7 |
Tuesday, April 20, 2004 |
Meeting 10 |
Thursday, April 22, 2004 |
Meeting 11 |
Chamber sittings
| Sitting date | Debates (Hansard) |
|---|---|
Friday, April 23, 2004 |
End of stage activity
Concurrence at report stage with further amendments, Wednesday, April 28, 2004
Chamber sittings
| Sitting date | Debates (Hansard) |
|---|---|
Wednesday, April 28, 2004 |
End of stage activity
Third reading, Tuesday, May 4, 2004
Chamber sittings
| Sitting date | Debates (Hansard) |
|---|---|
Thursday, April 29, 2004 |
|
Tuesday, May 4, 2004 |
Senate
End of stage activity
First reading, Tuesday, May 4, 2004
Chamber sittings
| Sitting date | Debates (Hansard) |
|---|---|
Tuesday, May 4, 2004 |
End of stage activities
Second reading, Tuesday, May 11, 2004
Referral to committee, Tuesday, May 11, 2004
Chamber sittings
| Sitting date | Debates (Hansard) |
|---|---|
Thursday, May 6, 2004 |
|
Monday, May 10, 2004 |
|
Tuesday, May 11, 2004 |
End of stage activity
Committee report presented, Thursday, May 13, 2004
Committee meetings
| Meeting date | Details |
|---|---|
Wednesday, May 12, 2004 |
Meeting 10 |
Chamber sittings
| Sitting date | Debates (Hansard) |
|---|---|
Thursday, May 13, 2004 |
End of stage activity
Third reading, Thursday, May 13, 2004
Chamber sittings
| Sitting date | Debates (Hansard) |
|---|---|
Thursday, May 13, 2004 |
Notes
Pursuant to Order made by the House of Commons on February 10, 2004, the Bill was deemed approved at all stages completed in the previous session (previously Bill C-56 in the 2nd Session of the 37th Parliament).
Details
Recorded votes
House of Commons
There are currently no recorded votes for this bill.
Senate
To view the complete list of standing votes that have taken place in the Senate, please refer to the Votes page of the Senate of Canada website.Speaker's rulings and statements
There are currently no Speaker's rulings and statements.
Major speeches at second reading
Senate
| Speech date | Speech | |
|---|---|---|
| Thursday, May 6, 2004 | Sponsor’s speech(Sitting 38) | |
| Thursday, May 6, 2004 | Response speech(Sitting 38) |
About
Legislative summary
A legislative summary of this bill is available from the Library of Parliament.
Similar bills
From the Library of Parliament
The Library of Parliament’s research publications provide non-partisan, reliable and timely information and analysis on current and emerging issues, legislation and major public policy topics.
Further reading
A war over drugs and patents.
The Economist, 358:43-4
Accès des pays pauvres aux soins et aux médicaments : un espoir enfin?.
Lethu, Thérèse.
Problèmes économiques, no 2722:10-13
Distributive politics and international institutions: the case of drugs.
Benvenisti, Eyal and George W. Downs.
Case Western Reserve journal of international law, 36:21-51
Drug-induced dilemma.
The Economist, 359:59-60
Experts clash over liklely impact of cheap AIDS drugs in Africa.
Wadman, Meredith.
Nature, 410:615-16
FTAA [Free Trade Agreement of the Americas] could interfere with proposed Canadian patent legislation allowing generic exports.
Silversides, Ann.
CMAJ:Canadian Medical Association journal, 170:937
Hold-up sur le médicament.
Velasquez, German.
Le Monde diplomatique, no 592:1, 26-7
In Africa, patents kill.
Shulman, Seth.
Technology review, 104:37
Intellectual property - patents and copyright.
Hore, Ed.
Canadian lawyer, 28:31, 33
Intellectual property and the AIDS pandemic.
Kossick, Don.
Briar patch, 35:12-15
Intellectual property and the AIDS pandemic.
Kossick, Don.
Briar patch, 35:12-15
Martin government to reintroduce patent changes.
Eggertson, Laura.
CMAJ:Canadian Medical Association journal, 170:456
Medicines for the developing world: promoting access and innovation in the post-TRIPS environment.
Morgan, Maxwell R.
University of Toronto Faculty of Law review, 64:45-111
New free trade agreement could make generic drugs less accessible in the Americas.
Silversides, Ann.
CMAJ: Canadian Medical Association journal, 170:935, 937
No turning back on cheap AIDS drugs for poor nations, UN vows.
Silversides, Anne.
CMAJ:Canadian Medical Association journal, 169:1067
Out-licensing: a practical approach for improvement of access to medicines in poor countries.
Friedman, Michael A., Henk den Besten and Amir Attaran.
The Lancet, 361:341-44
Protection racket: drugs companies are tightening their hold on Third World markets.
MacKenzie, Debora.
New scientist, 171:18-19
Symptomatic relief: drugs, patents and the WTO.
The Economist, 368:13
The G8 fails global health.
Orbinski, James.
CMAJ:Canadian Medical Association journal, 167:481-2
The WTO dispute settlement understanding: an unlikely weapon in the fight against AIDS.
Curti, Andrea M..
American journal of law and medicine, 27:469-85